Cogentix Medical Inc  

(Public, NASDAQ:CGNT)   Watch this stock  
Find more results for NASDAQ:VSCI
0.00 (0.00%)
Feb 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 0.71 - 2.99
Open     -
Vol / Avg. 0.00/68,857.00
Mkt cap 129.76M
P/E     -
Div/yield     -
EPS -0.16
Shares 60.35M
Beta 0.91
Inst. own 40%

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 0.79% -
Operating margin 3.88% -
EBITD margin - -
Return on average assets 0.87% -
Return on average equity 3.13% -
Employees 178 -
CDP Score - -


5420 Feltl Rd
MINNETONKA, MN 55343-7982
United States - Map
+1-952-4266140 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

Officers and directors

Uri Geiger Chairman of the Board
Age: 48
Bio & Compensation  - Reuters
Darin Hammers President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Brett A. Reynolds Chief Financial Officer, Senior Vice President, Principal Financial Officer, Principal Accounting Officer, Secretary
Age: 47
Bio & Compensation  - Reuters
Kenneth H. Paulus Director
Age: 56
Bio & Compensation  - Reuters
Cheryl Pegus M.D. Director
Age: 51
Bio & Compensation  - Reuters
Lewis C. Pell Director
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kevin H. Roche Director
Age: 64
Bio & Compensation  - Reuters
Nachum Shamir Director
Age: 62
Bio & Compensation  - Reuters